In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses the use of home pulse oximetry monitoring for COVID-19, cannabinoid hyperemesis syndrome, and other highlights from ACEP Now’s February issue.
By Jeremy Samuel Faust, MD, MS, MA, FACEP
|
on May 14, 2021
|
0 Comment
Topics: Airwaycannabinoid hyperemesis syndromeCannabiscoronavirusCOVID-19MarijuanaPulse Oximetry
Related
-
Current Extraglottic Airway Devices and Prehospital Practices
November 8, 2024 - 0 Comment -
Case Report: Uvular Edema in a Marijuana Smoker
November 5, 2024 - 0 Comment -
By the Numbers: Cannabis-Related Emergency Department Visits in New Jersey
August 11, 2024 - 0 Comment
Current Issue
About the Author
Jeremy Samuel Faust, MD, MS, MA, FACEP
Jeremy Samuel Faust, MD, MS, MA, FACEP, is Medical Editor in Chief of ACEP Now, an instructor at Harvard Medical School and an attending physician in department of emergency medicine at Brigham & Women’s Hospital in Boston. Follow him on twitter @JeremyFaust.
No Responses to “February 2021: Pulse Oximetry in COVID-19”